NCT07420127

Brief Summary

Cesarean section is one of the commonly performed surgical procedures in the world. Once baby is delivered during the surgical procedure anesthesiologist administer Oxytocin drug through IV cannula which helps the Uterus to contract so that excessive blood loss doesnt occur. But this is associated with fall in blood pressure frequently requiring administration of medications to treat low blood pressure. The most frequently used drug is phenylephrine which can administered along with oxytocin to prevent fall in blood pressure. This study will compare to different doses of Phenylephrine to prevent fall in blood pressure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for phase_4

Timeline
2mo left

Started Feb 2026

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Feb 2026Jul 2026

First Submitted

Initial submission to the registry

February 12, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

February 13, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 19, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2026

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

February 12, 2026

Last Update Submit

February 21, 2026

Conditions

Keywords

PhenylephrineOxytocin induced hypotension

Outcome Measures

Primary Outcomes (1)

  • Number of Hypotensive episodes

    Hypotension will be defined as fall in Mean Arterial pressure by more than 20% from baseline value.

    Number of hypotensive episodes occuring upto 10 minutes after administration of Oxytocin and Phenylephrine

Secondary Outcomes (1)

  • Rescue Phenylephrine consumed

    This will be the total amount of Phenylephrine consumed to treat the hypotensive episodes occuring upto 10 minutes after administration of Oxytocin and Phenylephrine

Study Arms (2)

Phenylephrine 75

ACTIVE COMPARATOR
Drug: Phenylephrine bolus 75 micrograms

Phenylephrine 50

ACTIVE COMPARATOR
Drug: Phenylephrine bolus 50 micrograms

Interventions

After delivery of Baby during C section, patient will be administered 3 IU of Oxytocin over 3 minutes along with 75 micrograms of Phenylephrine Intravenously.

Phenylephrine 75

After delivery of Baby during C section, patient will be administered 3 IU of Oxytocin over 3 minutes along with 50 micrograms of Phenylephrine Intravenously.

Phenylephrine 50

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- Females having a singleton pregnancy Patients planned for elective cesarean section under spinal anesthesia

You may not qualify if:

  • Patients having a placental abnormality
  • Patients taking beta-blocker and vasodilator therapy
  • Patients with hypertensive disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia, Holy Family Hospital, Rawalpindi

Rawalpindi, Punjab Province, 46000, Pakistan

RECRUITING

Related Publications (1)

  • Sharma N, Agarwal S, Modi YC, Yadav A, Yadav J, Sindhi R, et al. Effect of Two Different Doses of Intravenous Phenylephrine on the Prevention of Oxytocin Induced Hypotension in Lower Segment Caesarean Section Under Subarachnoid Block: A Randomised Controlled Study. J Clin Diagn Res. 2023;17(9):16-21.

    BACKGROUND

Study Officials

  • Jawad Zahir

    Head of Department of Anesthesia

    STUDY CHAIR

Central Study Contacts

Farwa Javed Principal Investigator, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 12, 2026

First Posted

February 19, 2026

Study Start

February 13, 2026

Primary Completion (Estimated)

July 13, 2026

Study Completion (Estimated)

July 13, 2026

Last Updated

February 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

It is not allowed by Hospital Ethical Committee

Locations